This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northeastern University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Lauren Chapman: Innovator in Cannabinoid Modulation
Introduction
Lauren Chapman is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of cannabinoid research, particularly through her innovative patent related to the modulation of cannabinoid receptors.
Latest Patents
Chapman's most notable patent is titled "Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors." This patent discloses compounds and compositions that inhibit the action of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL). The methods outlined in her patent aim to modulate cannabinoid receptors and provide potential treatments for various disorders related to these receptors. She holds 1 patent in this area.
Career Highlights
Lauren Chapman is affiliated with Northeastern University, where she continues her research and development in cannabinoid modulation. Her work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Chapman collaborates with esteemed colleagues, including Alexandros Makriyannis and Lakshmipathi Pandarinathan, who contribute to her research endeavors.
Conclusion
Lauren Chapman is a trailblazer in the field of cannabinoid research, with her innovative patent paving the way for future advancements in the modulation of cannabinoid receptors. Her contributions are poised to impact the treatment of various disorders significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile